Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • Patient Story Featured at World Cancer Congress

    The inspiring story of lung cancer survivor Pam G. put a human face on cancer immunotherapy.

    January 14, 2015| Matthew Tontonoz
  • Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer

    The results of a phase III trial are clear: the PD-1 checkpoint inhibitor nivolumab improves survival for…

    January 13, 2015| Matthew Tontonoz
  • Could That Steak Be Giving You Cancer?

    A CRI postdoctoral fellow was part of the team investigating the relation of red meat to cancer…

    January 9, 2015| Matthew Tontonoz
  • Wall Street Journal Article Profiles Cancer Immunotherapy ‘Super Survivors’

    Cancer Research Institute scientists, and the patients they have treated, are the subject of a new article…

    December 5, 2014| Matthew Tontonoz
  • Immunotherapy Featured on NBC Sports

    Leukemia survivor Milton Wright highlighted during Thanksgiving's 49ers vs. Seahawks half-time show.

    December 2, 2014| Matthew Tontonoz
  • Found: A Molecular Needle in the Cancer Haystack

    New research by CRI scientists shows how genomic methods can be used to create a personalized cancer…

    November 27, 2014| Matthew Tontonoz
  • Birth of the Lab Mouse

    Was the father of cancer immunotherapy also the father of the modern lab mouse?

    November 14, 2014| Matthew Tontonoz
  • CAR T Cell Therapy Surges Forward

    Researchers at the University of Pennsylvania publish latest results on an experimental immunotherapy using genetically engineered T…

    October 16, 2014| Matthew Tontonoz
  • The Arrival of Personalized Immunotherapy?

    A new paper from a CRI scientist makes a strong case f or the value of truly…

    October 10, 2014| Matthew Tontonoz

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal